Human recombinant BTLA (from HEK293 cells)
Catalog # PRSI96-067
Supplier: ProSci Inc.
CAS Number:
Specifications
- VE:100 µG
- Protein/Peptid-Typ:Rekombinant
- Ursprung:HEK293 cells
- Spezies:Human
- Proteinsynonym:BTLA|CD272
- Protein/Peptid-Name:BTLA
- Purity:>90% as determined by SDS-PAGE.
- Molecular weight:38.7 kDa
- Zusammensetzung:Lyophilized, 50 mM tris, 100 mM glycine, pH7.5
- Validierte Anwendungen:Western Blot
Specifications
About this item
B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.